首页> 外文期刊>Japanese Journal of Cancer Research >The intraductal carcinoma component is a significant prognostic parameter in patients with invasive ductal carcinoma of the pancreas.
【24h】

The intraductal carcinoma component is a significant prognostic parameter in patients with invasive ductal carcinoma of the pancreas.

机译:导管内癌成分是胰腺浸润性导管癌患者的重要预后参数。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We have sometimes encountered invasive ductal carcinomas (IDCs) of the pancreas containing intraductal carcinoma components in the intra- and / or extra-tumor area. The purpose of this study was to investigate whether intraductal carcinoma components would be useful for predicting the outcome of IDC patients. Forty-seven surgically treated IDCs were examined, and all histological tumor sections were stained with Elastica to accurately confirm intraductal carcinoma components. Well-known clinicopathological parameters that exhibited a significant correlation in the univariate analyses for predicting disease-free survival (DFS) and overall survival (OS) were entered into the Cox proportional hazard multivariate analysis. Since the lowest P-value predicting DFS or OS periods was observed in IDCs with more than 10% intraductal carcinoma components and those with 10% or less intraductal carcinoma components (P = 0.028 and P = 0.019), we established the cutoff value of intraductal carcinoma components at 10%. In the multivariate analyses for DFS and OS, the presence of more than 10% intraductal carcinoma components showed a marginally significant increase in the hazard rate (HR) of tumor recurrence (P = 0.067) and significantly increased the HR of mortality (P = 0.040). The present study demonstrated that IDCs with more than 10% intraductal carcinoma components were associated with a significantly better patient outcome than those with 10% or less intraductal carcinoma components.
机译:我们有时会在肿瘤内和/或肿瘤外区域遇到含有导管内癌成分的胰腺浸润性导管癌(IDC)。这项研究的目的是调查导管内癌成分是否可用于预测IDC患者的预后。检查了47个手术治疗的IDC,并用Elastica对所有组织学肿瘤切片进行了染色,以准确确认导管内癌成分。将在单变量分析中显示出显着相关性的众所周知的临床病理参数预测无病生存期(DFS)和总体生存期(OS)纳入Cox比例风险多元分析。由于在导管内癌成分超过10%的导管癌和导管内癌成分少于或等于10%的IDC中观察到最低的D值预测DFS或OS周期(P = 0.028和P = 0.019),因此我们确定了导管内癌成分占10%。在DFS和OS的多变量分析中,存在超过10%的导管内癌成分表明,肿瘤复发的危险率(HR)略有增加(P = 0.067),并且死亡率的HR显着增加(P = 0.040) )。本研究表明,导管内癌成分多于10%的IDC与导管内癌成分少于10%或更少的IDC的患者预后明显相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号